Viatris Inc (VTRS): Share Repurchases
$500.50M
Year ended 2025-12-31
$300.10M
Trailing 12 months to 2026-06-30
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $500.50M | +100.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $250.00M | 0.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $250.00M | n/a | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $0 | n/a | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $0 | n/a | 2021-03-01, From 2020-01-01 |
| 2019-12-31 | $0 | -100.0% | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | $432.00M | n/a | 2021-03-01, From 2018-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Viatris Inc (VTRS) | 2025-12-31 | $500.50M | +100.2% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.44B | +32.1% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $2.02B | +71.4% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.23B | +74.1% |
| Abbott Laboratories (ABT) | 2025-12-31 | $893.00M | -31.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $125.02M | -59.9% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $0 | n/a |
| AbbVie Inc. (ABBV) | 2025-12-31 | $980.00M | -42.6% |
| Pfizer Inc (PFE) | 2024-12-31 | $0 | n/a |
Compare VTRS, REGN, VRTX, ZTS side by side · Screen every company in Pharmaceutical Preparations ↗